We are live on
!
Find out more
CCM
Crossvault Capital Management Portfolio holdings
AUM
$254M
1-Year Est. Return
5.07%
This Fund
S&P 500
This Quarter
Est. Return
+14.33%
1 Year Est. Return
-5.07%
3 Year Est. Return
+56.38%
5 Year Est. Return
+114.39%
10 Year Est. Return
–
AUM
$194M
AUM Growth
+$17.8M
(+10%)
Cap. Flow
-$4.78M
Cap. Flow
% of AUM
-2.46%
Top 10 Holdings %
Top 10 Hldgs %
45.6%
Holding
83
New
7
Increased
18
Reduced
28
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$5.1M |
| 2 |
XYZ
Block Inc
XYZ
|
+$2.33M |
| 3 |
Microsoft
MSFT
|
+$783K |
| 4 |
Netflix
NFLX
|
+$754K |
| 5 |
Workday
WDAY
|
+$493K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.22M |
| 2 |
Intel
INTC
|
+$5.06M |
| 3 |
UnitedHealth
UNH
|
+$1.4M |
| 4 |
Kraft Heinz
KHC
|
+$559K |
| 5 |
Abbott
ABT
|
+$527K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.55% |
| 2 | Technology | 17.16% |
| 3 | Healthcare | 13.03% |
| 4 | Consumer Discretionary | 13.03% |
| 5 | Financials | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.66T
| $11.1M | 5.75% |
125,200
+140
| +0.1% | +$11.7K |
|
2
Boeing
BA
$169B
| $10.5M | 5.42% |
27,550
+935
| +4% | +$360K |
|
3
Apple
AAPL
$4.9T
| $10.1M | 5.21% |
212,948
-820
| -0.4% | -$34.8K |
|
|
4
Microsoft
MSFT
$2.93T
| $9.95M | 5.13% |
84,353
+7,180
| +9% | +$783K |
|
5
Visa
V
$682B
| $9.75M | 5.03% |
62,405
+100
| +0.2% | +$14.4K |
|
6
Honeywell
HON
$71.3B
| $7.88M | 4.06% |
52,603
+399
| +0.8% | +$55.8K |
|
7
Lockheed Martin
LMT
$117B
| $7.87M | 4.06% |
26,227
+640
| +3% | +$188K |
|
8
Home Depot
HD
$338B
| $7.23M | 3.73% |
37,671
-324
| -0.9% | -$59.4K |
|
9
Johnson & Johnson
JNJ
$609B
| $7.01M | 3.62% |
50,185
| – | – |
|
10
Alphabet (Google) Class A
GOOGL
$4.23T
| $6.98M | 3.6% |
118,640
+660
| +0.6% | +$37.3K |
|
11
ConocoPhillips
COP
$140B
| $6.19M | 3.19% |
92,810
-1,405
| -1% | -$94.5K |
|
12
JPMorgan Chase
JPM
$907B
| $5.98M | 3.08% |
59,054
-1,935
| -3% | -$199K |
|
13
PNC Financial Services
PNC
$101B
| $5.79M | 2.99% |
47,229
-574
| -1% | -$71.1K |
|
14
Rockwell Automation
ROK
$51.4B
| $5.74M | 2.96% |
32,698
+1,091
| +3% | +$186K |
|
15
Salesforce
CRM
$140B
| $5.69M | 2.94% |
35,940
-125
| -0.3% | -$19.4K |
|
16
PepsiCo
PEP
$187B
| $5.31M | 2.74% |
43,353
-65
| -0.1% | -$7.41K |
|
|
17
Regeneron Pharmaceuticals
REGN
$70.9B
| $5.09M | 2.62% |
+12,385
| New | +$5.1M |
|
18
Nike
NKE
$64.9B
| $4.75M | 2.45% |
56,385
-3,096
| -5% | -$255K |
|
19
RTX Corp
RTX
$261B
| $4.46M | 2.3% |
54,943
-4,740
| -8% | -$360K |
|
20
Intuitive Surgical
ISRG
$122B
| $4.11M | 2.12% |
21,630
+1,260
| +6% | +$224K |
|
|
21
Netflix
NFLX
$290B
| $3.68M | 1.9% |
103,180
+21,750
| +27% | +$754K |
|
22
AT&T
T
$152B
| $3.03M | 1.56% |
127,916
-264
| -0.2% | -$6.07K |
|
|
XYZ
23
Block Inc
XYZ
$47.6B
| $2.91M | 1.5% |
38,815
+32,165
| +484% | +$2.33M |
|
24
Chevron
CVX
$373B
| $2.58M | 1.33% |
20,976
-10
| -0% | -$1.18K |
|
25
Gilead Sciences
GILD
$167B
| $2.5M | 1.29% |
38,444
-2,300
| -6% | -$153K |
|
Similar funds
HA
PPW
SG
ETI
RIM
TF
TWM
IC
Crossvault Capital Management's Q1 2019 Portfolio in Review
As of Q1 2019, Crossvault Capital Management held 83 positions worth $194M, up 10% from $176M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Crossvault Capital Management's Q1 2019 filing shows 7 new, 18 increased, 28 reduced and 6 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 12,385 shares worth $5.09M. The largest sale was Bristol-Myers Squibb, an estimated $6.22M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- Crossvault Capital Management's largest Q1 2019 buy was Regeneron Pharmaceuticals: 12,385 shares worth $5.09M.
- Crossvault Capital Management added most to Block Inc in Q1 2019, an estimated $2.33M increase.
- Crossvault Capital Management's biggest Q1 2019 reduction was Intel, cutting an estimated $5.06M.
- Crossvault Capital Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $6.22M.
- Crossvault Capital Management's ten largest holdings make up 46% of its $194M portfolio in Q1 2019.
- Crossvault Capital Management opened 7 new positions and closed 6 in Q1 2019.
- Crossvault Capital Management's portfolio value rose 10% quarter-over-quarter to $194M.
Based on Crossvault Capital Management's 13F filing for Q1 2019, filed 24 Apr 2019.